Sg3 Management, LLC Moderna, Inc. Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$225.82 - $368.51 $7.56 Million - $12.3 Million	-33,500 Reduced 63.81%	19,000 $4.83 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $3.02 Million - $6.59 Million	13,600 Added 34.96%	52,500 $20.2 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $1.94 Million - $3.5 Million	14,900 Added 62.08%	38,900 $9.14 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $712,080 - $1.92 Million	24,000 New	24,000 $1.54 Million

928

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.2B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.